World's Best Scientists 2026 revealed!
Antonella Sarasini

Antonella Sarasini

D-Index & Metrics

Immunology

D-Index
50
Citations
8623
World Ranking
4256
National Ranking
178

Antonella Sarasini publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Antonella Sarasini sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 131 publications — 10th percentile

10% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Antonella Sarasini D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Antonella Sarasini sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 50 D-Index — 15th percentile

15% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Antonella Sarasini is affiliated with the University of Pavia in Italy, focusing primarily on medicine with a substantial emphasis on infectious diseases. Their research spans several subfields including epidemiology, oncology, neurology, and health.

Their work extensively covers topics related to SARS-CoV-2 and COVID-19, encompassing clinical research studies, detection and testing methodologies, as well as vaccine coverage and hesitancy. Additionally, their research interests include the impacts of COVID-19 on healthcare systems and investigations into cytomegalovirus and herpesvirus infections and treatments.

Some of the recent papers authored or co-authored by Sarasini include:

  • Mechanism of baricitinib supports artificial intelligence-predicted testing in COVID-19 patients, 2020, EMBO Molecular Medicine
  • Persistence of SARS-CoV-2-specific B and T cell responses in convalescent COVID-19 patients 6-8 months after the infection, 2021, Med
  • Clinical and Analytical Performance of an Automated Serological Test That Identifies S1/S2-Neutralizing IgG in COVID-19 Patients Semiquantitatively, 2020, Journal of Clinical Microbiology
  • SARS-CoV-2 vaccine breakthrough infections with the alpha variant are asymptomatic or mildly symptomatic among health care workers, 2021, Nature Communications
  • West Nile or Usutu Virus? A Three-Year Follow-Up of Humoral and Cellular Response in a Group of Asymptomatic Blood Donors, 2020, Viruses

Frequent collaborators in Sarasini's research include:

  • Fausto Baldanti
  • Irene Cassaniti
  • Elena Percivalle
  • Daniele Lilleri
  • Alessandro Ferrari

Sarasini has published notably in venues such as:

  • ESMO Open
  • Clinical Microbiology and Infection
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Eurosurveillance
  • Microorganisms

Best Publications

  • Human Cytomegalovirus UL131-128 Genes Are Indispensable for Virus Growth in Endothelial Cells and Virus Transfer to Leukocytes

    Gabriele Hahn;Maria Grazia Revello;Marco Patrone;Elena Percivalle

  • Isolation of human monoclonal antibodies that potently neutralize human cytomegalovirus infection by targeting different epitopes on the gH/gL/UL128-131A complex.

    Annalisa Macagno;Nadia L. Bernasconi;Fabrizia Vanzetta;Erica Dander

  • Human cytomegalovirus serum neutralizing antibodies block virus infection of endothelial/ epithelial cells, but not fibroblasts, early during primary infection

    Giuseppe Gerna;Antonella Sarasini;Marco Patrone;Elena Percivalle

  • Mechanism of baricitinib supports artificial intelligence-predicted testing in COVID-19 patients.

    Justin Stebbing;Venkatesh Krishnan;Stephanie de Bono;Silvia Ottaviani

  • Human Cytomegalovirus in Blood of Immunocompetent Persons during Primary Infection: Prognostic Implications for Pregnancy

    Maria Grazia Revello;Maurizio Zavattoni;Antonella Sarasini;Elena Percivalle

  • Sequential mutations associated with adaptation of human cytomegalovirus to growth in cell culture

    Derrick J. Dargan;Elaine Douglas;Charles Cunningham;Fiona Jamieson

  • Single amino acid changes in the DNA polymerase confer foscarnet resistance and slow-growth phenotype, while mutations in the UL97-encoded phosphotransferase confer ganciclovir resistance in three double-resistant human cytomegalovirus strains recovered from patients with AIDS.

    Fausto Baldanti;Mark R. Underwood;Sylvia C. Stanat;Karen K. Biron

  • Isolation and characterization of two distinct human rotavirus strains with G6 specificity.

    G Gerna;A Sarasini;M Parea;S Arista

  • Genetic variability of human coronavirus OC43-, 229E-, and NL63-like strains and their association with lower respiratory tract infections of hospitalized infants and immunocompromised patients.

    Giuseppe Gerna;Giulia Campanini;Francesca Rovida;Elena Percivalle

  • High Levels of Epstein-Barr Virus DNA in Blood of Solid-Organ Transplant Recipients and Their Value in Predicting Posttransplant Lymphoproliferative Disorders

    Fausto Baldanti;Paolo Grossi;Milena Furione;Lavinia Simoncini

  • Fetal human cytomegalovirus transmission correlates with delayed maternal antibodies to gH/gL/pUL128-130-131 complex during primary infection.

    Daniele Lilleri;Anna Kabanova;Maria Grazia Revello;Elena Percivalle

  • Clinical and Analytical Performance of an Automated Serological Test That Identifies S1/S2-Neutralizing IgG in COVID-19 Patients Semiquantitatively.

    Fabrizio Bonelli;Antonella Sarasini;Claudia Zierold;Mariella Calleri

  • Persistence of SARS-CoV-2 specific B- and T-cell responses in convalescent COVID-19 patients 6-8 months after the infection.

    Natalia Sherina;Antonio Piralla;Likun Du;Hui Wan

  • Diagnostic and prognostic value of human cytomegalovirus load and IgM antibody in blood of congenitally infected newborns.

    Maria Grazia Revello;Maurizio Zavattoni;Fausto Baldanti;Antonella Sarasini

  • Comparative quantitation of human cytomegalovirus DNA in blood leukocytes and plasma of transplant and AIDS patients.

    G Gerna;M Furione;F Baldanti;A Sarasini

  • In vitro selection of human cytomegalovirus variants unable to transfer virus and virus products from infected cells to polymorphonuclear leukocytes and to grow in endothelial cells

    M. Grazia Revello;Fausto Baldanti;Elena Percivalle;Antonella Sarasini

  • Human respiratory coronavirus HKU1 versus other coronavirus infections in Italian hospitalised patients.

    Giuseppe Gerna;Elena Percivalle;Antonella Sarasini;Giulia Campanini

  • Severe acute respiratory syndrome coronavirus 2 RNA contamination of inanimate surfaces and virus viability in a health care emergency unit.

    M. Colaneri;E. Seminari;S. Novati;E. Asperges

  • Improved prenatal diagnosis of congenital human cytomegalovirus infection by a modified nested polymerase chain reaction

    Maria Grazia Revello;Antonella Sarasini;Maurizio Zavattoni;Fausto Baldanti

  • A three-nucleotide deletion in the UL97 open reading frame is responsible for the ganciclovir resistance of a human cytomegalovirus clinical isolate.

    F Baldanti;E Silini;A Sarasini;C L Talarico

  • Persistence of SARS-CoV-2 specific B- and T-cell responses in convalescent COVID-19 patients 6-8 months after the infection

    Natalia Sherina;Antonio Piralla;Likun Du;Hui Wan

Frequent Co-Authors

Fausto Baldanti
Fausto Baldanti University of Pavia
Giuseppe Gerna
Giuseppe Gerna University of Pavia
Elena Percivalle
Elena Percivalle University of Pavia
Daniele Lilleri
Daniele Lilleri University of Pavia
Maria Grazia Revello
Maria Grazia Revello University of Milan
Antonio Piralla
Antonio Piralla Policlinico San Matteo Fondazione
Yee-Joo Tan
Yee-Joo Tan National University of Singapore
Michael Hust
Michael Hust Technische Universität Braunschweig
Catherine Klersy
Catherine Klersy University of Pavia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in immunology, exploring related healthcare degrees can broaden career opportunities. Many professionals in immunology collaborate closely with nursing roles, making nursing programs a valuable pathway. If you’re seeking accessible entry points into nursing, consider the easiest accelerated nursing programs to get into, which can fast-track your education and enhance your clinical knowledge.

LPN programs also offer a practical route into patient care, with several programs known for their straightforward admission processes. Discover more about easy admission LPN programs that provide foundational skills for healthcare settings and can complement immunology careers focused on patient interaction and support.

For advanced clinical roles, nurse practitioner degrees are in high demand. Many aspiring practitioners search for easy nurse practitioner programs to get into, balancing quality education with accessible admissions to quickly enter specialized nursing fields.

Mental health is another critical area intersecting with immunology, especially in conditions where psychological and immune responses are linked. The top online PMHNP programs offer excellent clinical placement opportunities, preparing professionals for impactful roles in psychiatric mental health nursing while providing flexibility through online study.

Best Scientists Citing Antonella Sarasini

Trending Scientists